Marton JP - Search Results

1

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ. Xenakis JG, et al. Among authors: marton jp. Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000. Pharmacoeconomics. 2011. PMID: 21452908

2

Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.

Getsios D, Marton JP, Revankar N, Ward AJ, Willke RJ, Rublee D, Ishak KJ, Xenakis JG. Getsios D, et al. Among authors: marton jp. Pharmacoeconomics. 2013 Sep;31(9):767-80. doi: 10.1007/s40273-013-0070-5. Pharmacoeconomics. 2013. PMID: 23821436

3

Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US.

Yeomans K, Payne KA, Marton JP, Merikle EP, Proskorovsky I, Zou KH, Li Q, Willke RJ. Yeomans K, et al. Among authors: marton jp. Int J Clin Pract. 2011 Oct;65(10):1043-54. doi: 10.1111/j.1742-1241.2011.02758.x. Int J Clin Pract. 2011. PMID: 21923845

4

Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation.

Menzin J, Marton JP, Menzin JA, Willke RJ, Woodward RM, Federico V. Menzin J, et al. Among authors: marton jp. BMC Med Res Methodol. 2012 Jun 25;12:87. doi: 10.1186/1471-2288-12-87. BMC Med Res Methodol. 2012. PMID: 22731620 Free PMC article.

5

The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.

Knight C, Howard P, Baker CL, Marton JP. Knight C, et al. Among authors: marton jp. Value Health. 2010 Mar-Apr;13(2):209-14. doi: 10.1111/j.1524-4733.2009.00672.x. Epub 2009 Nov 13. Value Health. 2010. PMID: 19912599 Free article. Clinical Trial.

6

Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?

Menzin J, Lines LM, Marton J. Menzin J, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):257-64. doi: 10.1586/erp.09.28. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19527098 Review.

7

Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.

Tashkin DP, Rennard S, Taylor Hays J, Lawrence D, Marton JP, Lee TC. Tashkin DP, et al. Among authors: marton jp. Respir Med. 2011 Nov;105(11):1682-90. doi: 10.1016/j.rmed.2011.04.016. Epub 2011 May 31. Respir Med. 2011. PMID: 21621992 Free article. Clinical Trial.

8

A new method for examining the cost savings of reducing COPD exacerbations.

Mapel DW, Schum M, Lydick E, Marton JP. Mapel DW, et al. Among authors: marton jp. Pharmacoeconomics. 2010;28(9):733-49. doi: 10.2165/11535600-000000000-00000. Pharmacoeconomics. 2010. PMID: 20799755

9

The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.

Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, Phillips A, Shah H. Menzin J, et al. Respir Med. 2008 Sep;102(9):1248-56. doi: 10.1016/j.rmed.2008.04.009. Epub 2008 Jul 11. Respir Med. 2008. PMID: 18620852 Free article.

10

Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data.

Menzin J, Lang KM, Friedman M, Dixon D, Marton JP, Wilson J. Menzin J, et al. Among authors: marton jp. Value Health. 2005 Mar-Apr;8(2):140-8. doi: 10.1111/j.1524-4733.2005.04004.x. Value Health. 2005. PMID: 15804322 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters